Rosa Conforti

Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

Antonella Sistigu, Takahiro Yamazaki, Erika Vacchelli et al. · Nature Medicine · 2014 · 1K citations

Cancer Immunosurveillance, Medicine, Immunology +8

TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer

Bruno Salaun, Laurence Zitvogel, Carine Asselin‐Paturel et al. · Cancer Research · 2011 · 117 citations

Breast Oncology, Immunology, Pathology +16

Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands

Rosa Conforti, Yuting Ma, Yannis Morel et al. · Cancer Research · 2010 · 103 citations

Immunology, Toll-like Receptor, Pathology +20

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials

Rosa Conforti, Thomas Boulet, Gorana Tomasic et al. · Annals of Oncology · 2007 · 87 citations · Full text

Breast Oncology, Oncology, Medicine +8

CXCR4 Expression in Early Breast Cancer and Risk of Distant Recurrence

Fabrice André, Weiya Xia, Rosa Conforti et al. · The Oncologist · 2009 · 70 citations · Full text